Evidence-based recommendations on eluxadoline (Truberzi) for treating irritable bowel syndrome (IBS) with diarrhoea in adults
4 results for Eluxadoline
Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart
This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.
The drug, Truberzi has been recommended for routine funding on the NHS to treat patients with irritable bowel syndrome and diarrhoea (IBS-D).